The stock has a 36-month beta value of 3.17. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for COSM is 18.60M, and at present, short sellers hold a 2.89% of that float. On January 15, 2025, the average trading volume of COSM was 235.85K shares.
COSM) stock’s latest price update
Cosmos Health Inc (NASDAQ: COSM)’s stock price has soared by 12.55 in relation to previous closing price of 0.61. Nevertheless, the company has seen a loss of -1.76% in its stock price over the last five trading days. accesswire.com reported 2025-01-13 that CHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a distribution agreement with Virax Biolabs Group Limited (NASDAQ: VRAX) (“Virax”) to distribute Virax-branded Avian Influenza Virus (“AIV”) Real-Time PCR Kits across various major European markets and certain Gulf Cooperation Council (GCC) countries. Specifically, Cosmos Health gains exclusive rights to distribute these kits in Greece and Cyprus, as well as non-exclusive rights in select European countries, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria.
COSM’s Market Performance
Cosmos Health Inc (COSM) has seen a -1.76% fall in stock performance for the week, with a -10.84% decline in the past month and a -4.47% plunge in the past quarter. The volatility ratio for the week is 12.30%, and the volatility levels for the past 30 days are at 10.04% for COSM. The simple moving average for the past 20 days is 4.01% for COSM’s stock, with a -18.05% simple moving average for the past 200 days.
COSM Trading at -2.72% from the 50-Day Moving Average
After a stumble in the market that brought COSM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.47% of loss for the given period.
Volatility was left at 10.04%, however, over the last 30 days, the volatility rate increased by 12.30%, as shares sank -10.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.62% lower at present.
During the last 5 trading sessions, COSM fell by -1.76%, which changed the moving average for the period of 200-days by -3.11% in comparison to the 20-day moving average, which settled at $0.6612. In addition, Cosmos Health Inc saw 2.80% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at COSM starting from Siokas Grigorios, who purchase 163,666 shares at the price of $0.61 back on Jan 13 ’25. After this action, Siokas Grigorios now owns 3,937,980 shares of Cosmos Health Inc, valued at $100,000 using the latest closing price.
Terzis Georgios, the Chief Financial Officer of Cosmos Health Inc, purchase 85,778 shares at $0.58 during a trade that took place back on Dec 20 ’24, which means that Terzis Georgios is holding 727,263 shares at $50,000 based on the most recent closing price.
Stock Fundamentals for COSM
Current profitability levels for the company are sitting at:
- -0.36 for the present operating margin
- 0.08 for the gross margin
The net margin for Cosmos Health Inc stands at -0.36. The total capital return value is set at -0.51. Equity return is now at value -46.31, with -26.60 for asset returns.
Based on Cosmos Health Inc (COSM), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at -0.33. The debt to equity ratio resting at 0.32. The interest coverage ratio of the stock is -19.59.
Currently, EBITDA for the company is -17.06 million with net debt to EBITDA at -0.42. When we switch over and look at the enterprise to sales, we see a ratio of 0.42. The receivables turnover for the company is 3.21for trailing twelve months and the total asset turnover is 0.87. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
To sum up, Cosmos Health Inc (COSM) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
